News|Articles|August 2, 2023
How Patient Centricity is a Business Imperative for Life Sciences Companies
Author(s)ZS Associates
Patient centricity is an imperative focus for the advancement of life sciences businesses, and Sharon Suchotliff from ZS delves into this topic by sharing her keen insights.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Travere Therapeutics’ Filspari Receives Full FDA Approval
2
How Serious is the Biosimilar Void?
3
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
4
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
5